SCHEMBL25585274

SCHEMBL25585274

COCCOC(=O)CCC(=O)OCCOC(=O)[C@@H]1[C@H]2CC/C=C/CC[C@@H]2[C@@H]1C(=O)OC

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 3/20 0.36
▸ NPC1 O15118 2/20 0.36
▸ ALDH1A1 P00352 3/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33
▸ CYP2C19 P33261 1/20 0.33
▸ KMT2A Q03164 1/20 0.33
▸ PPM1B O75688 3/20 0.32
▸ PTPN1 P18031 3/20 0.32
▸ PPP1CC P36873 3/20 0.32
▸ USP2 O75604 1/20 0.32
▸ ALOX15 P16050 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32
▸ ADRA2A P08913 1/20 0.30
▸ ADRA1A P35348 1/20 0.30
▸ KDM4E B2RXH2 1/20 0.30
▸ TP53 P04637 1/20 0.30
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ GLA P06280 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26718289 1.00 RAB9A (0.36) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL25585245 0.96 RAB9A (0.34) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL26718299 0.86 RAB9A (0.39) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL26779366 0.83 RAB9A (0.41) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL25585235 0.81 RAB9A (0.40) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL26718282 0.81 RAB9A (0.40) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL25585168 0.79 RAB9A (0.50) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL26779020 0.78 RAB9A (0.38) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL25585134 0.73 PPM1B (0.49) RAB9ANPC1ALDH1A1MEN1CYP1A2
SCHEMBL25585228 0.73 PPM1B (0.49) RAB9ANPC1ALDH1A1MEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167211-A1 MONOMER ISOMERIZATION AND POLYMER FLUORINATION FOR SUSTAINABLE DEPOLYMERIZABLE POLYMERS THE UNIVERSITY OF AKRON 2023-06-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167211-A1 MONOMER ISOMERIZATION AND POLYMER FLUORINATION FOR SUSTAINABLE DEPOLYMERIZABLE POLYMERS PFAS, PARG, MFAP1 RAB9A 2902/4885NPC1 4113/4885ALDH1A1 3329/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback